Literature DB >> 11181552

Regional trabecular bone matrix degeneration and osteocyte death in femora of glucocorticoid- treated rabbits.

A W Eberhardt1, A Yeager-Jones, H C Blair.   

Abstract

Glucocorticoids at pharmacological concentrations cause osteoporosis and aseptic necrosis, particularly in the proximal femur. Several mechanisms have been proposed, but the primary events are not clear. We studied changes in the bone structure and cellular activity in femora of glucocorticoid-treated rabbits before the occurrence of fracture or collapse. In rabbits treated 28 days with 4 micromol/kg.day of methylprednisolone acetate, changes in the cortical bone were minor. However, metabolic labeling showed that bone formation was virtually absent in the subarticular trabecular bone, and scanning electron microscopy showed resorption of 50-80% of the trabecular surface. Thus, reduction in bone synthesis and increased resorption were involved in bone loss. Vascular changes, which have been hypothesized to mediate glucocorticoid damage, were not seen, but histological changes suggested that trabecular bone was damaged. Matrix integrity was examined using laser scanning confocal microscopy to detect passive tetracycline adsorption. In treated animals, but not controls, tetracycline was adsorbed, in a novel lamellar pattern, in 50--200 microm regions extending deep into trabeculae. This showed that the matrix, which is normally impervious, was exposed at these sites. TUNEL assays showed that matrix damage correlated with cell death in the subarticular trabecular bone of treated animals. The pattern of cell death involving cohorts of osteoblasts and osteocytes comprised up to half of the bone volume in affected regions and is consistent with an apoptotic mechanism. Small numbers of TUNEL-labeled osteoblasts, but no osteocytes, were detected in control bone. We conclude that exposure of bone matrix permeability and that regional cell death consistent with apoptosis is an early event in glucocorticoid-induced bone damage.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11181552     DOI: 10.1210/endo.142.3.8048

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  35 in total

Review 1.  Glucocorticoid-induced osteonecrosis.

Authors:  Robert S Weinstein
Journal:  Endocrine       Date:  2011-12-15       Impact factor: 3.633

2.  Regulation of bim in glucocorticoid-mediated osteoblast apoptosis.

Authors:  B Espina; M Liang; R G G Russell; P A Hulley
Journal:  J Cell Physiol       Date:  2008-05       Impact factor: 6.384

Review 3.  Calcium and bone disease.

Authors:  Harry C Blair; Lisa J Robinson; Christopher L-H Huang; Li Sun; Peter A Friedman; Paul H Schlesinger; Mone Zaidi
Journal:  Biofactors       Date:  2011-06-14       Impact factor: 6.113

4.  Adrenocorticotropic hormone and 1,25-dihydroxyvitamin D3 enhance human osteogenesis in vitro by synergistically accelerating the expression of bone-specific genes.

Authors:  Irina L Tourkova; Li Liu; Nareerat Sutjarit; Quitterie C Larrouture; Jianhua Luo; Lisa J Robinson; Harry C Blair
Journal:  Lab Invest       Date:  2017-07-24       Impact factor: 5.662

5.  Osteoblast Differentiation and Bone Matrix Formation In Vivo and In Vitro.

Authors:  Harry C Blair; Quitterie C Larrouture; Yanan Li; Hang Lin; Donna Beer-Stoltz; Li Liu; Rocky S Tuan; Lisa J Robinson; Paul H Schlesinger; Deborah J Nelson
Journal:  Tissue Eng Part B Rev       Date:  2016-12-27       Impact factor: 6.389

Review 6.  High-density lipoprotein (HDL) metabolism and bone mass.

Authors:  Nicholaos I Papachristou; Harry C Blair; Kyriakos E Kypreos; Dionysios J Papachristou
Journal:  J Endocrinol       Date:  2017-03-17       Impact factor: 4.286

7.  STAT1-caspase 3 pathway in the apoptotic process associated with steroid-induced necrosis of the femoral head.

Authors:  Xinxian Xu; Hong Wen; Yuezheng Hu; Huachen Yu; Yu Zhang; Chengwang Chen; Xiaoyun Pan
Journal:  J Mol Histol       Date:  2014-02-20       Impact factor: 2.611

Review 8.  Bone quality: the determinants of bone strength and fragility.

Authors:  Hélder Fonseca; Daniel Moreira-Gonçalves; Hans-Joachim Appell Coriolano; José Alberto Duarte
Journal:  Sports Med       Date:  2014-01       Impact factor: 11.136

9.  Characterization of a rabbit osteoporosis model induced by ovariectomy and glucocorticoid.

Authors:  Li Baofeng; Yuan Zhi; Chen Bei; Meng Guolin; Yin Qingshui; Liu Jian
Journal:  Acta Orthop       Date:  2010-06       Impact factor: 3.717

10.  Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response.

Authors:  G J Atkins; K J Welldon; P Halbout; D M Findlay
Journal:  Osteoporos Int       Date:  2008-09-02       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.